ScholarLens Back to search
2020•NeurologyRequires access

Health Utilities and Acceptable States in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) – Preliminary data (1827)

Meg Mendoza, Hans Katzberg, Vera Bril, Carolina Barnett Tapia

Open publisher page 0 citations

Abstract

Current guidelines for assessing CIDP patients and their response to treatment are centered on expert definitions of good outcomes. While there are several CIDP patient-reported measures, we currently do not have a patient-anchored definition of what constitutes a “good” outcome. Therefore, we do not have a clear threshold when to escalate or stop CIDP treatment from the patient perspective.

About this research paper

What this paper is about

Current guidelines for assessing CIDP patients and their response to treatment are centered on expert definitions of good outcomes. While there are several CIDP patient-reported measures, we currently do not have a patient-anchored definition of what constitutes a “good” outcome. Therefore, we do not have a clear threshold when to escalate or stop CIDP treatment from the patient perspective.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Current guidelines for assessing CIDP patients and their response to treatment are centered on expert definitions of good outcomes. While there are several CIDP patient-reported measures, we currently do not have a patient-anchored definition of what constitutes a “good” outcome. Therefore, we do not have a clear threshold when to escalate or stop CIDP treatment from the patient perspective.

Key concepts: Chronic inflammatory demyelinating polyneuropathy, Medicine, Polyneuropathy, Polyradiculoneuropathy, Pediatrics, Immunology, Guillain-Barre syndrome, Internal medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Health Utilities and Acceptable States in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) – Preliminary data (1827) — Research Paper | ScholarLens